AstraZeneca says detained China head has lawyer

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...
British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that led to the detention ...
Recently Leon Wang, EVP International and AstraZeneca China President was detained. The Company has not received any notification that it is itself under investigation. If requested, ...
Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...
The U.K. drugmaker also announced plans to drop another $2 billion on expanding its R&D and manufacturing footprint in the ...
STORY: Drugmaker AstraZeneca has lifted its annual sales and profit forecast for the second time this year, as third-quarter results beat estimates.It's been helped by strong demand for its cancer and ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
Astrazeneca is set to report earnings next week after a turbulant few months for the FTSE 100 firm and its China arm.